Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease.

Söderman J, Norén E, Christiansson M, Bragde H, Thiébaut R, Hugot JP, Tysk C, O'Morain CA, Gassull M, Finkel Y, Colombel JF, Lémann M, Almer S.

World J Gastroenterol. 2013 Aug 14;19(30):4935-43. doi: 10.3748/wjg.v19.i30.4935.

2.

The association of MYO9B gene in Italian patients with inflammatory bowel diseases.

Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.

Aliment Pharmacol Ther. 2008 Feb 1;27(3):241-8. Epub 2007 Oct 15.

3.

Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.

Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL.

World J Gastroenterol. 2013 Oct 21;19(39):6656-64. doi: 10.3748/wjg.v19.i39.6656. Review.

4.

Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis.

Giri AK, Midha S, Banerjee P, Agrawal A, Mehdi SJ, Dhingra R, Kaur I, G RK, Lakhotia R, Ghosh S, Das K, Mohindra S, Rana S, Bhasin DK, Garg PK, Bharadwaj D; INDIPAN and INDICO Consortium.

PLoS One. 2016 Jan 28;11(1):e0147345. doi: 10.1371/journal.pone.0147345. eCollection 2016.

5.

Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.

Blom K, Rubin J, Halfvarson J, Törkvist L, Rönnblom A, Sangfelt P, Lördal M, Jönsson UB, Sjöqvist U, Håkansson LD, Venge P, Carlson M.

World J Gastroenterol. 2012 Nov 28;18(44):6409-19; discussion p. 6417-8. doi: 10.3748/wjg.v18.i44.6409.

6.

The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.

de Vries HS, te Morsche RH, van Oijen MG, Nagtegaal ID, Peters WH, de Jong DJ.

PLoS One. 2010 Nov 24;5(11):e15011. doi: 10.1371/journal.pone.0015011.

7.

Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis.

Diaz-Gallo LM, Medrano LM, Gómez-García M, Cardeña C, Rodrigo L, Mendoza JL, Taxonera C, Nieto A, Alcain G, Cueto I, López-Nevot MA, Urcelay E, Martin J.

Hum Immunol. 2011 Oct;72(10):969-72. doi: 10.1016/j.humimm.2011.05.028. Epub 2011 Jun 17.

PMID:
21684315
8.

Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.

Mahurkar S, Banerjee R, Rani VS, Thakur N, Rao GV, Reddy DN, Chandak GR.

J Gastroenterol Hepatol. 2011 Apr;26(4):694-9. doi: 10.1111/j.1440-1746.2010.06533.x.

PMID:
21155887
9.

Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study.

Derikx MH, Kovacs P, Scholz M, Masson E, Chen JM, Ruffert C, Lichtner P, Te Morsche RH, Cavestro GM, Férec C, Drenth JP, Witt H, Rosendahl J; PanEuropean Working group on Alcoholic Chronic Pancreatitis Members and Collaborators.

Gut. 2015 Sep;64(9):1426-33. doi: 10.1136/gutjnl-2014-307453. Epub 2014 Sep 24.

PMID:
25253127
10.

Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.

Senhaji N, Serbati N, Diakité B, Arazzakou S, Hamzi K, Badre W, Nadifi S.

Gene. 2013 May 25;521(1):45-9. doi: 10.1016/j.gene.2013.02.046. Epub 2013 Mar 28.

PMID:
23542077
11.

Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.

Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19.

PMID:
19455129
12.

A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in Crohn's disease.

Connelly TM, Koltun WA, Berg AS, Hegarty JP, Brinton D, Deiling S, Poritz LS, Stewart DB.

Dis Colon Rectum. 2013 Sep;56(9):1068-74. doi: 10.1097/DCR.0b013e31829de128.

PMID:
23929016
13.

IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies.

Corleto VD, Pagnini C, Margagnoni G, Guagnozzi D, Torre MS, Martorelli M, Latiano A, Annese V, Caprilli R, Delle Fave G.

Dig Liver Dis. 2010 Mar;42(3):179-84. doi: 10.1016/j.dld.2009.06.016. Epub 2009 Jul 29.

PMID:
19643686
14.

CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.

Oostenbrug LE, Nolte IM, Oosterom E, van der Steege G, te Meerman GJ, van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH.

Dig Liver Dis. 2006 Nov;38(11):834-45. Epub 2006 Aug 21.

PMID:
16920047
15.

CD209 in inflammatory bowel disease: a case-control study in the Spanish population.

Núñez C, Oliver J, Mendoza JL, Gómez-García M, Taxonera C, Gómez LM, López-Nevot MA, de la Concha EG, Urcelay E, Martínez A, Martín J.

BMC Med Genet. 2007 Dec 10;8:75.

16.

Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population.

Can G, Tezel A, Gürkan H, Can H, Yılmaz B, Ünsal G, Soylu AR, Ümit HC.

Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):489-98. doi: 10.1016/j.clinre.2015.01.005. Epub 2015 Mar 2.

PMID:
25744728
17.

Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population.

Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M.

Dig Liver Dis. 2008 Sep;40(9):723-30. doi: 10.1016/j.dld.2008.02.011. Epub 2008 Apr 3.

PMID:
18394979
18.

CARD15 gene polymorphisms in Serbian patients with Crohn's disease: genotype-phenotype analysis.

Protic MB, Pavlovic ST, Bojic DZ, Krstic MN, Radojicic ZA, Tarabar DK, Stevanovic AZ, Karan Djurasevic TZ, Godjevac MV, Svorcan PV, Dapcevic BD, Jojic NZ.

Eur J Gastroenterol Hepatol. 2008 Oct;20(10):978-84. doi: 10.1097/MEG.0b013e328302f45e.

PMID:
18787464
19.

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy NA, Kupcinskas L, Lawrance IC, Lee JC, Satsangi J, Schreiber S, Théâtre E, van der Meulen-de Jong AE, Weersma RK, Wilson DC; International Inflammatory Bowel Disease Genetics Consortium, Parkes M, Vermeire S, Rioux JD, Mansfield J, Silverberg MS, Radford-Smith G, McGovern DP, Barrett JC, Lees CW.

Lancet. 2016 Jan 9;387(10014):156-67. doi: 10.1016/S0140-6736(15)00465-1. Epub 2015 Oct 18.

20.

Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.

Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2009 Jul;104(7):1737-44. doi: 10.1038/ajg.2009.163. Epub 2009 May 19.

PMID:
19455118

Supplemental Content

Support Center